Investors

Guggenheim Venture Partners (GVP) focuses on investments in early-stage, emerging technologies, particularly within the networking, communications, and components industries. The investment team also specializes by region, with offices in the Mid-Atlantic, Southwest and Pacific Northwest.

GVP is a subsidiary of Guggenheim Partners, LLC, a global diversified financial services firm with wealth management, capital markets, investment management and proprietary investing businesses. Guggenheim Partners clients are an elite mix of individuals, family offices, endowments, foundations, insurance companies, pension plans, and other institutions that together have entrusted the firm with supervision of more than $110 billion in assets. Office locations include New York, Chicago, Los Angeles, Miami, Boston, Philadelphia, St. Louis, Houston, London, Hong Kong and Geneva.

TL Ventures focuses its resources on investing in early-stage, high- technology companies in software, communications, information infrastructure and business services.

Since 1988, they have invested in more than 200 companies across the United States. Our team has been where you are now, solving real-world problems as entrepreneurs and business professionals. They offer all the boardroom support a start-up would expect from a traditional venture capital firm plus functional and operational management experience.

TL Ventures works with their portfolio companies through each stage of growth and help to build solid organizations and accelerate their success. Over 45 of their investments have achieved liquidity through initial public offerings or trade sales. At TL Ventures, they believe in collaborating with their entrepreneurial partners and providing responsive involvement to a company's needs.

Venrock is a premier venture capital firm with offices in Menlo Park, New York, Cambridge, MA, and Israel. Originally established as the venture capital arm of the Rockefeller family, Venrock continues a seven-decade tradition of funding entrepreneurs and establishing successful, enduring companies. Having invested $1.8 billion in 400 companies resulting in over 120 IPOs over the past 38 years, Venrock’s investment returns place it among the top tier venture capital firms that have achieved consistently superior performance. With a primary focus on information technology, healthcare, and energy, portfolio companies have included Intel, Apple Computer, StrataCom, Check Point Software, DoubleClick, Sirna Therapeutics, Centocor, Idec Pharmaceuticals, Sugen, Millennium Pharmaceuticals, and Illumina.